Yulin Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- Immune cells in cancer
Papers in
-
- RNA Interference and Gene Delivery 9
- Muscle Physiology and Disorders 7
- S100 Proteins and Annexins 6
-
- Cardiac Fibrosis and Remodeling 15
- Co-authors
- Jie Du (65 shared papers)Congcong Zhang (26 shared papers)Hui‐Hua Li (11 shared papers)Dean W. Felsher (8 shared papers)Stephanie C. Casey (5 shared papers)Lixin Jia (13 shared papers)Yina Wu (10 shared papers)Martin Eilers (1 shared paper)
- Journals
- PLoS ONE (6 papers)Nature Communications (5 papers)Advanced Science (5 papers)Journal of Biological Chemistry (5 papers)Cardiovascular Toxicology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yulin Li
210 papers receiving 7.1k citations
Yulin Li's Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 1.1k
- Immunology 1.3k
- Cardiology and Cardiovascular Medicine 1.1k
- Molecular Biology 2.9k
- Oncology 962
Countries citing papers authored by Yulin Li
This map shows the geographic impact of Yulin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulin Li more than expected).
Fields of papers citing papers by Yulin Li
This network shows the impact of papers produced by Yulin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulin Li. The network helps show where Yulin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yulin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MYC regulates the antitumor immune response through CD47 and PD-L1 Hit paper breakdown → | 2016 | 1042 |
| 2 | Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury Hit paper breakdown → | 2017 | 335 |
| 3 | 2019 | 245 | |
| 4 | 2012 | 237 | |
| 5 | 2012 | 232 | |
| 6 | 2006 | 224 | |
| 7 | 2013 | 161 | |
| 8 | 2014 | 134 | |
| 9 | 2017 | 124 | |
| 10 | 2014 | 116 | |
| 11 | 2013 | 114 | |
| 12 | 2014 | 110 | |
| 13 | 2013 | 103 | |
| 14 | 2015 | 94 | |
| 15 | 2014 | 93 | |
| 16 | 2018 | 91 | |
| 17 | 2012 | 90 | |
| 18 | 2015 | 88 | |
| 19 | 2012 | 84 | |
| 20 | 2012 | 81 |
About Yulin Li
Yulin Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 221 papers that have together received 7.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cardiac Fibrosis and Remodeling (15 papers), Aortic Disease and Treatment Approaches (10 papers), Aortic aneurysm repair treatments (10 papers), RNA Interference and Gene Delivery (9 papers), Muscle Physiology and Disorders (7 papers), IL-33, ST2, and ILC Pathways (6 papers) and S100 Proteins and Annexins (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (1.3k citations), Cardiology and Cardiovascular Medicine (1.1k citations), Molecular Biology (2.9k citations) and Oncology (962 citations). Yulin Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jie Du, Congcong Zhang, Hui‐Hua Li, Dean W. Felsher, Stephanie C. Casey, Lixin Jia, Yina Wu, Martin Eilers, Ling Tong and Susanne Walz. Their work appears in journals such as PLoS ONE, Nature Communications, Advanced Science, Journal of Biological Chemistry and Cardiovascular Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.